Assessing efficacy in early-phase cancer prevention trials: the case of oral premalignancy
- PMID: 19138975
- DOI: 10.1158/1940-6207.CAPR-08-0171
Assessing efficacy in early-phase cancer prevention trials: the case of oral premalignancy
Comment on
-
A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions.Cancer Prev Res (Phila). 2008 Oct;1(5):339-48. doi: 10.1158/1940-6207.CAPR-07-0003. Cancer Prev Res (Phila). 2008. PMID: 19138978 Clinical Trial.
Similar articles
-
Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.Cancer Res. 1994 Apr 1;54(7 Suppl):2015s-2024s. Cancer Res. 1994. PMID: 8137331 Review.
-
Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "Aberrant crypt foci in the adenoma prevention with celecoxib trial".Cancer Prev Res (Phila). 2008 Aug;1(3):215-6; author reply 216. doi: 10.1158/1940-6207.CAPR-08-0094. Cancer Prev Res (Phila). 2008. PMID: 19138959 No abstract available.
-
Design and endpoints of clinical trials in hepatocellular carcinoma.J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. J Natl Cancer Inst. 2008. PMID: 18477802 Review.
-
Implications of recent Australian epidemiological studies for cancer prevention through dietary change.Prog Clin Biol Res. 1990;346:35-44. Prog Clin Biol Res. 1990. PMID: 2197630 Review. No abstract available.
-
Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.Clin Ther. 2005 Nov;27(11):1671-84. doi: 10.1016/j.clinthera.2005.11.013. Clin Ther. 2005. PMID: 16368441 Review.
Cited by
-
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.Oral Oncol. 2013 Sep;49(9):970-976. doi: 10.1016/j.oraloncology.2013.05.011. Epub 2013 Jul 8. Oral Oncol. 2013. PMID: 23845699 Free PMC article. Clinical Trial.
-
Assessing efficacy in early-phase cancer prevention clinical trials: the case of ki-67 in the lung.Cancer Prev Res (Phila). 2010 Feb;3(2):128-31. doi: 10.1158/1940-6207.CAPR-09-0268. Epub 2010 Jan 26. Cancer Prev Res (Phila). 2010. PMID: 20103726 Free PMC article. Review.
-
Retinoid chemoprevention trials: cyclin D1 in the crosshairs.Cancer Prev Res (Phila). 2009 Jan;2(1):3-6. doi: 10.1158/1940-6207.CAPR-08-0218. Cancer Prev Res (Phila). 2009. PMID: 19139010 Free PMC article. Review. No abstract available.
-
Kava, a tonic for relieving the irrational development of natural preventive agents.Cancer Prev Res (Phila). 2008 Nov;1(6):409-12. doi: 10.1158/1940-6207.CAPR-08-0172. Cancer Prev Res (Phila). 2008. PMID: 19138987 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
